Healthcare AI expert Parminder Bhatia has been appointed to the Board of Directors of Helio Genomics to advance cancer diagnostics with AI innovations.

Helio Genomics has joined forces with Syneos Health to promote HelioLiver™, a pioneering AI-driven blood test, for early liver cancer diagnosis across America.

Discover how the HelioLiver™ multi-analyte blood test enhances early liver cancer detection compared to ultrasound, transforming patient care immensely.

Helio Genomics forms a strategic partnership with LiverRight to improve access to early liver cancer detection and expert care for patients across the U.S.

The American Liver Foundation and Helio Genomics team up to improve liver cancer detection and educate the public about its risks via an at-home testing solution.

Helio Genomics has appointed Dr. Bharat Tewarie as CEO, leveraging his expertise to accelerate growth and innovation in AI-powered cancer diagnostics.

At the 2025 Digestive Disease Week, Helio Genomics introduced vital findings from three studies demonstrating enhanced cancer detection through blood tests.

At the 2025 Digestive Disease Week in San Diego, Helio Genomics will present new advancements in early cancer detection through blood tests aimed at diagnosing hepatocellular carcinoma.